APRE
Aprea Therapeutics, Inc. Common stock
$1.07
0.00%
0.00
Notify me if price changes either direction
Buy APRE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
6.7M
Enterprise value
-6301377
Trailing PE
0.47928512
Forward PE
-1.0392157
PEG Ratio
-0.018043675105882
Enterprise to EBITDA
0.457
Enterprise to revenue
-12.906
Price to book MRQ
0.5808219
Price to sales TTM
13.700901
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
488.2K
EBITDA
-13795074
Diluted EPS TTM
-2.12
Total Cash (MRQ)
13.7M
Current ratio (MRQ)
5.201
Operating Cash Flow (TTM)
-13444051
APRE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
December 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
